Escitalopram (Lexapro) for the Treatment of Postpartum Depression
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether women with postpartum major depressive
disorder (MDD) will experience a significant decrease in depressive symptoms from baseline
over an eight-week treatment intervention with escitalopram (Lexapro). Also, to determine
whether women with postpartum MDD will experience a significant decrease in anxiety symptoms.